How OpioidHALT tackles pre-operative opioid use
The OpioidHALT intervention is tailored to the needs of individual patients and evaluated for safety by a pain specialist. Shared decision-making, with the patient, is an important feature… read more.
The OpioidHALT intervention is tailored to the needs of individual patients and evaluated for safety by a pain specialist. Shared decision-making, with the patient, is an important feature… read more.
FIP’s Early Career in Pharmaceutical Practice Recognition Award recognises an outstanding early career pharmacist who has made significant contributions to the field at a national level and is… read more.
Opioid doses can be successfully reduced by a pharmacy-led intervention, according to a randomised study led by Dr Shania Liu and Dr Jonathan Penm at the University of… read more.
Paul Rutter is Professor of Pharmacy Practice at Portsmouth University and the author of a best-selling textbook on symptoms, diagnosis and treatment in community pharmacy. His new book… read more.
The introduction of clinical reasoning and diagnosis as routine elements of community pharmacy practice will present a number of challenges and could pave the way for closer working… read more.
Clinical reasoning skills are essential for effective consultations that lead to likely diagnoses and appropriate treatment or referral, argues Paul Rutter, Professor of Pharmacy Practice at Portsmouth University… read more.
Paul Rutter is Professor of Pharmacy Practice at Portsmouth University and the author of a best-selling textbook on symptoms, diagnosis and treatment in community pharmacy. His new book… read more.
Kieron Power is Principal Pharmacist for Thrombosis and Anticoagulation in Swansea Bay University Health Board in South Wales. He has played a leading role in the development of… read more.
A number of features have contributed to the success of the pharmacy-led outpatient PE pathway including a close working relationship with the doctors, the systematic delivery of seven-day… read more.
Evaluation of the new outpatient pulmonary embolism pathway showed that about 30% of patients could be managed safely and effectively via this route. Kieron Power, Principal Pharmacist for… read more.
The pulmonary embolism pathway has been designed to ensure acute risk assessment and appropriate follow up for all pulmonary embolism patients whether treated as inpatients or outpatients, according… read more.
Improved diagnostic techniques mean that many more low-risk pulmonary embolisms are being diagnosed now. However, a recent national report identified numerous shortcomings in the management of pulmonary embolism… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.